Nureca Limited has informed the exchange regarding the Investor Presentation.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nureca Limited submitted its Q4 and FY26 investor presentation. The company reported strong operational performance with FY26 operating profit of ₹8.5 Cr versus a loss of ₹7.5 Cr in FY25, marking a turnaround after three consecutive years of losses. FY26 revenue grew 34% YoY to ₹146.96 Cr with PAT at ₹2.1 Cr (up 145%). However, Q4 FY26 showed a PAT loss of ₹6.1 Cr due to fair value changes on investments. The company is debt-free with 90%+ revenue from online sales and operates its own manufacturing subsidiary (Nureca Technologies Pvt Ltd). Key strengths include 305+ active SKUs, 102 design patents, USFDA/CE approvals, and leadership position on e-commerce platforms with 1.86 crore happy families using products.
The operational turnaround is positive for long-term investors, though Q4 losses from investment fair value changes may create short-term volatility. The company's debt-free status and improving profitability metrics are encouraging signs.